Vertex Pharmaceuticals Incorporated H-1B Third-Party Placement Rate
Of 673 certified H-1B filings from Vertex Pharmaceuticals Incorporated (FY2022–2026), 0% record the worker's actual worksite as a client site rather than Vertex Pharmaceuticals Incorporated's own location, the DOL disclosure field used for staffing and consulting placements.
What This Measures
DOL requires every Labor Condition Application to state whether the H-1B worker's actual worksite is the petitioning employer's own location or a client's site under a staffing or consulting arrangement. This page reports that field only, it is not a measure of job security, legitimacy, or employer quality. Third-party placement is a normal, lawful business model in IT staffing and consulting, and a low or 0% rate simply means an employer's H-1B roles are filed for its own offices rather than client engagements.
What it can tell you: whether an offer from Vertex Pharmaceuticals Incorporated is more likely to mean working at Vertex Pharmaceuticals Incorporated's own office, or being placed at a separate client company's site.
Related H-1B Data
⚖️Need H1B legal guidance?
Navigate visa petitions, transfers, and green card pathways with expert immigration attorneys.
Find an AttorneyH1B Visa Jobs Research Team
Computed from US Department of Labor LCA disclosure files (FY2022–2026) for Vertex Pharmaceuticals Incorporated, using DOL's secondary-worksite disclosure field, filtered to certified petitions with annual wages between $30K and $1M. This measures where the LCA states the work is performed, not employer quality, job security, or legitimacy, third-party placement is a normal, lawful business model.